Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a three-day suspension order for a drug license at its Ganeshpeth, Hubli store. The suspension, resulting from alleged violations of the Drugs and Cosmetics Act, carries a potential revenue loss of Rs 0.97 lacs. Operations at the affected location were impacted following the receipt of the order on April 30, 2026.
Details of Operational Suspension
MedPlus Health Services Limited has reported a regulatory action affecting one of its retail stores in Hubli, Karnataka. The subsidiary, Optival Health Solutions Private Limited, received an order from the local Drugs Control Administration, mandating a three-day suspension of the drug license for the store located in Ganeshpeth. The order was officially received by the company on April 30, 2026.
Impact Assessment
The suspension was issued following alleged contraventions of the Drugs and Cosmetics Act, 1940 and associated rules. While the regulatory action restricts pharmacy operations at this specific site for the duration of the three-day period, the company has quantified the potential financial impact as a revenue loss of Rs 0.97 lacs. The company continues to monitor compliance across its retail network to ensure adherence to operational standards.
Source: BSE
